Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengling Ma

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Thrombosis and Haemostasis : JTH|February 5, 2025
Incidence and risk of arterial thromboembolism in cancer patients from a safety-net healthcare systemRock Bum Kim, Justine H Ryu, Danielle Guffey, et al.
Thrombosis Research|June 25, 2023
Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantationJonathan Avery, Danielle Guffey, Shengling Ma, et al.
Frontiers in Oncology|August 8, 2022
Development of a Novel Prognostic Model of Glioblastoma Based on m6A-Associated Immune Genes and Identification of a New BiomarkerNa Luo, Xizi Sun, Shengling Ma, et al.
Frontiers in Cell and Developmental Biology|April 11, 2022
Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach AdenocarcinomaMin Fu, Yongbiao Huang, Xiaohong Peng, et al.
Journal of Racial and Ethnic Health Disparities|July 2, 2024
Racial and Ethnic Disparity for Cancer Mortality in General and Single-Payer Healthcare Systems in the United StatesRock Bum Kim, Emily Zhou, Kaitlin N Swinnerton, et al.
Transplantation and Cellular Therapy|August 19, 2023
Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic MicroangiopathyShengling Ma, Saleh Bhar, Danielle Guffey, et al.
Transplantation and Cellular Therapy|December 21, 2025
Temporal Biomarker Dynamics and Clinical Outcomes in Transplant-Associated Thrombotic Microangiopathy (TA-TMA)Mrinal Ranjan, Saleh Bhar, Pavan K Bhatraju, et al.
Leukemia|June 30, 2025
SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cellsMoran Wang, Ruiqi Zhu, Donald Small, et al.
American Journal of Hematology|June 4, 2026
Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort StudyMing Y Lim, Radhika Gangaraju, Omid Jafari, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2024
Circulating tumor DNA predicts venous thromboembolism in patients with cancersShengling Ma, Jun Yang Jiang, Rock Bum Kim, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Thrombosis and Haemostasis : JTH|February 5, 2025
Incidence and risk of arterial thromboembolism in cancer patients from a safety-net healthcare systemRock Bum Kim, Justine H Ryu, Danielle Guffey, et al.
Thrombosis Research|June 25, 2023
Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantationJonathan Avery, Danielle Guffey, Shengling Ma, et al.
Frontiers in Oncology|August 8, 2022
Development of a Novel Prognostic Model of Glioblastoma Based on m6A-Associated Immune Genes and Identification of a New BiomarkerNa Luo, Xizi Sun, Shengling Ma, et al.
Frontiers in Cell and Developmental Biology|April 11, 2022
Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach AdenocarcinomaMin Fu, Yongbiao Huang, Xiaohong Peng, et al.
Journal of Racial and Ethnic Health Disparities|July 2, 2024
Racial and Ethnic Disparity for Cancer Mortality in General and Single-Payer Healthcare Systems in the United StatesRock Bum Kim, Emily Zhou, Kaitlin N Swinnerton, et al.
Transplantation and Cellular Therapy|August 19, 2023
Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic MicroangiopathyShengling Ma, Saleh Bhar, Danielle Guffey, et al.
Transplantation and Cellular Therapy|December 21, 2025
Temporal Biomarker Dynamics and Clinical Outcomes in Transplant-Associated Thrombotic Microangiopathy (TA-TMA)Mrinal Ranjan, Saleh Bhar, Pavan K Bhatraju, et al.
Leukemia|June 30, 2025
SIRT5 inhibition impairs mitochondrial metabolism and enhances venetoclax-induced elimination of acute myeloid leukemia cellsMoran Wang, Ruiqi Zhu, Donald Small, et al.
American Journal of Hematology|June 4, 2026
Clinically Relevant Bleeding in Individuals With Cancer: Insights From a Nationwide Cohort StudyMing Y Lim, Radhika Gangaraju, Omid Jafari, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2024
Circulating tumor DNA predicts venous thromboembolism in patients with cancersShengling Ma, Jun Yang Jiang, Rock Bum Kim, et al.
Pageof 3